NovaBiotics Ltd

Tweet this page
Registration as it was on 23 Feb 2023
How to read and use this data card.
Download this datacard


Lobbying Costs


Financial year: Dec 2021 - Nov 2022

Lobbyists (Full time equivalent)

0.5 Fte (1)

Lobbyists with EP accreditation


High-level Commission meetings


Lobbying Costs over the years

  • Info

    NovaBiotics Ltd

    EU Transparency Register

    080907239314-61 First registered on 01 Sep 2020

    Goals / Remit

    NovaBiotics Ltd is a leading clinical-stage biotechnology company focused on leveraging its novel immunology platforms to design and develop first-in-class therapies to address difficult-to-treat, medically unmet diseases.
    We are in the midst of a worsening global antimicrobials resistance (AMR) crisis. There is an urgent need for new classes of antibacterial, antifungal and other antimicrobial treatments to address range of challenging infectious diseases that can no longer be resolved with existing drugs. The Company’s advanced portfolio of therapeutic candidates target life-threatening and life-limiting diseases in the inflammation, infection and respiratory space.
    The Company’s advanced portfolio of antimicrobial therapeutic candidates targets large and important markets with significant unmet clinical needs.

    Main EU files targeted

    We believe that financial incentives are needed to help implementation of R&D actions (PUSH) and fixing the broken market for AMR related products (PULL). This will greatly enable industry to retain focus on developing innovative AMR solutions. As an SME, we are a core part of the AMR innovation pipeline and hope to be part of the conversation to enable our work to continue. Main interests lie in
    : the Pharmaceutical Strategy, SME Strategy, Horizon Europe Partnerships - Innovative Health
    Initiative (IHI) Partnership, European Partnership for One Health Antimicrobial Resistance and European Partnership on Innovative SMEs - European Innovation Council (EIC), InvestEU, AMR Joint Action, Innovative Medicines Initiative and the EU4Health Programme.


    Head Office
    Unit 3 Silverburn Crescent Bridge of Don Industrial Estate
    Aberdeen AB23 8EW
    EU Office
    Unit 3 Silverburn Crescent Bridge of Don Industrial Estate
    Aberdeen AB23 8EW


  • People

    Total lobbyists declared


    Employment timeLobbyists

    Lobbyists (Full time equivalent)


    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories


    Non-governmental organisations, platforms and networks and similar

  • Networking


    Scottish Lifesciences Association

    BioIndustry Association

    Beam Alliance

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Dec 2021 - Nov 2022

    Lobbying costs for closed financial year


    Major contributions in closed year

    None declared

    Intermediaries for closed year

    None declared

    Intermediaries for current year

    None declared

    Closed year Costs

    0€ - 10,000€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)


    Groups (European Parliament)

    SME#Competitive European Industry: long-term and sustainable investment

    Other activities

    We are a member of the BEAM Alliance

  • Meetings


    None declared

Download this datacard